Most clinical trials split Ca-AKG into two doses, taken in the morning and evening, for a total of 1 to 2 grams per day. This twice-daily approach makes sense given how quickly your body breaks down alpha-ketoglutarate: once it reaches your bloodstream, it has a half-life of just a few minutes. Splitting your dose keeps levels more consistent throughout the day.
Morning and Evening Dosing
The largest ongoing clinical trials use a morning-and-evening schedule. In one randomized trial studying aging markers in middle-aged adults, participants take two tablets in the morning and two in the evening, totaling 2 grams per day over 12 weeks. Another well-designed trial, called ABLE, uses a single 1-gram sustained-release tablet daily, which is formulated to release the compound slowly and reduce the need for multiple doses.
Alpha-ketoglutarate is metabolized extremely rapidly in the gut lining and liver. When researchers measured its clearance from blood, the half-life was under five minutes. That speed of breakdown is the main reason split dosing or sustained-release formulations are preferred. Taking your entire daily amount at once means your body clears most of it before it can circulate widely.
With or Without Food
Clinical trial protocols don’t consistently specify whether Ca-AKG should be taken with meals, but there’s a useful clue from absorption research. A mildly acidic environment and the presence of iron enhance AKG uptake. Both of those conditions are more common during a meal, especially one that contains some iron-rich food like meat, legumes, or leafy greens. Vitamin C (ascorbate) also works synergistically with AKG and iron to support collagen production, so taking it alongside a meal that includes some vitamin C is reasonable.
That said, Ca-AKG is a calcium salt, and calcium can compete with iron for absorption at high doses. At the 500 mg to 1 gram amounts used in longevity studies, this is unlikely to be a major issue, but if you’re also taking a separate iron supplement, spacing them apart by an hour or two is a practical precaution.
How Much to Take
Human studies have used a wide range of doses, from 1 gram per day up to 6 grams per day, depending on the goal. For biological aging, the most commonly studied doses are 1 to 2 grams daily. The ABLE trial uses just 1 gram per day of a sustained-release formulation. The Rejuvant trial, which reported an average 8-year reduction in biological age after about 7 months, used a formulation combining alpha-ketoglutarate with vitamins at roughly 1 gram of AKG per day.
Higher doses have been tested for other purposes. Postmenopausal women in one study took 6 grams per day safely for six months to support bone density. Kidney dialysis patients have tolerated up to 4.5 grams per day without significant problems. For most people interested in the longevity angle, 1 to 2 grams per day is the dose range with the best balance of evidence and practicality.
What Age to Start
Your body produces alpha-ketoglutarate naturally as part of cellular energy metabolism, and levels decline with age. The clinical trials focused on aging have enrolled participants between 40 and 60 years old, specifically selecting people whose biological age (measured by DNA methylation patterns) already exceeded their chronological age. That 40-to-60 window is where researchers believe the supplement has the most potential to close the gap between how old your cells look and how old you actually are.
There’s no established evidence that younger, healthy adults benefit from Ca-AKG supplementation for aging purposes. If you’re in your 30s with no particular health concern driving you toward it, the research simply hasn’t been done in your age group for this use.
How Long Before Results Appear
The Rejuvant study found that participants showed measurable reductions in biological age after 4 to 10 months of daily use, with a median treatment duration of about 7 months. The researchers noted that 7 months appeared to be enough time to reach the full benefit of supplementation, suggesting the effects may plateau rather than continue accumulating indefinitely. The ABLE trial is structured as a 6-month intervention with a 3-month follow-up, which aligns with that timeline.
This is not a supplement where you’ll notice dramatic changes in a week or two. The measurable outcomes in studies are things like shifts in DNA methylation patterns, inflammatory markers, and metabolic indicators, not immediate physical sensations.
Side Effects and Cautions
Ca-AKG has a generally clean safety profile at the doses used in aging research. Trials using up to 4.5 grams per day in medically complex patients reported no serious adverse effects. The most common complaints at higher doses are mild gastrointestinal discomfort: bloating, nausea, or loose stools.
One important distinction: Ca-AKG (calcium alpha-ketoglutarate) is not the same as AAKG (arginine alpha-ketoglutarate), which is marketed as a pre-workout supplement. AAKG has been linked to emergency department visits involving palpitations, dizziness, and fainting, likely due to its effects on blood vessel dilation through the arginine component. Ca-AKG does not carry that same risk because it doesn’t contain arginine. If you’re shopping for a longevity-focused supplement, make sure the label specifies calcium alpha-ketoglutarate, not the arginine form.
Because Ca-AKG contains calcium, people with a history of hypercalcemia or calcium-based kidney stones should factor the additional calcium load into their daily intake. At 1 gram of Ca-AKG per day, the calcium content is modest, but it still adds up if you’re already getting calcium from other supplements and dairy.